- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03427723
Accuvein Versus Standard Care for Intravenous Cannulation Procedure in Children (AVEn)
Peripheral Intravenous Cannulation in Children With Difficult Vein Access : Randomized Study Comparing Accuvein®400 Versus Standard Care
Peripheral intravenous cannulation is one of the most common procedures performed in children admitted to hospital. It is a painful and anxiety-provoking gesture for children with possible memorization of the pain even more present for patients with chronic pathology. Nevertheless, this care is essential to administer the treatments.
The cannulation is usually set up by the observation and touching of the veins by the nurse. However, this technique is often insufficient in young children and especially infants because they have a higher thickness adipose tissue. Their veins are of small caliber, hardly visible and palpable which increases the probability of a failure of the insertion of the catheter at the first attempt.
In the literature, different techniques are mentioned to promote the visualization of veins and thus the insertion of cannulation. The AccuVein®400 (AV400) system uses an infrared laser beam to project the image of superficial veins to the skin. In adults, AV400 has been shown to improve the success rate of insertion cannulation when venous capital is precarious. The question now arises as to whether this tool could be of interest to children who are particularly difficult to assist cannulation, especially the youngest of them.
Investigator hypothesize that AV400 could bring a benefit to the placement of cannulation, in the child with a venous capital difficult to catheterize and thus increase the success of the cannulation at the first attempt.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Children admitted to pediatric emergencies, pediatric day hospitals and the general pediatric ward, who are less than 3 years old and whose care requires the placement of a cannulation will be identified by the caregivers as potentially included.
The DIVA score will be carried out by the nurse who takes care of the child thanks to the dedicated form. If the child has an Emla® patch, this score will be achieved after removing the patch. The nurse that will achieve the score will be the same that will pose the intravenous cannulation. Children with an assessment score <4 will not be included in the study but will still be counted.
The nurse must perform the randomization by inquiring about the randomization week: standard method or AV400 method.
The information will be made to the parents and the information form given. The parents' consent regarding the care of their child will be collected by the same nurse.
The means of prevention of pain and distraction will be set up in box with the nurse and / or the auxiliary childcare and the parents. Peripheral intravenous cannulation will be performed by the nurse in collaboration with the auxiliary childcare.
Caregivers and parents will evaluate the care. The documents concerning the practical realization of the study will be grouped together and made available in each service in dedicated bins.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Clermont-Ferrand, France, 63003
- Recruiting
- CHU Clermont-Ferrand
-
Principal Investigator:
- Etienne MERLIN
-
Sub-Investigator:
- Alexandra USCLADE
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Child under 3 years old (male or female) managed at the University Hospital of Clermont-Ferrand with an indication of the placement of a peripheral intravenous access,
- Represented by a person having parental authority,
- Parents or holder of parental authority capable of giving their consent to the study.
Exclusion Criteria:
- Need for urgent medical care
- Care practiced by a student nurse or pediatric nurse
- Refusal of the child or the holder of parental authority.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Standard care
visualization and palpation
|
The intervention comes down to the randomization of the standard treatment versus Accuvein for peripheral intravenous cannulation
|
Experimental: Accuvein
system uses an infrared laser beam to project the image of superficial veins to the skin
|
The intervention comes down to the randomization of the standard treatment versus Accuvein for peripheral intravenous cannulation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
successful of cannulation at first attempt
Time Frame: At day 1 (at the moment of peripheral intravenous cannulation)
|
Percentage of children whose peripheral intravenous cannulation, at first attempt, is successful.
|
At day 1 (at the moment of peripheral intravenous cannulation)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time required to install peripheral intravenous cannulation with AV400 and with the standard method
Time Frame: at day 1 (at the moment of peripheral intravenous cannulation)
|
time in minute for peripheral intravenous cannulation
|
at day 1 (at the moment of peripheral intravenous cannulation)
|
effectiveness of the care by the nurse and the parents thanks
Time Frame: at day 1 (at the moment of peripheral intravenous cannulation)
|
Score regarding the effectiveness of the care by the nurse and the parents thanks to the Lickert scale 5 points (from "not convinced at all" to "very convinced")
|
at day 1 (at the moment of peripheral intravenous cannulation)
|
pain assessment during insertion intravenous cannulation
Time Frame: at day 1 (at the moment of peripheral intravenous cannulation)
|
Score regarding pain during insertion intravenous cannulation by an hetero scale of pain assessment : FLACC (Face Legs Activity Cry Consolability).
Validated scale for acute pain during a care for children from 0 to 7 years
|
at day 1 (at the moment of peripheral intravenous cannulation)
|
Success rate according to the cannulation installation site
Time Frame: at day 1 (at the moment of peripheral intravenous cannulation)
|
percentage of successful of cannulation according to the cannulation installation site
|
at day 1 (at the moment of peripheral intravenous cannulation)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Etienne MERLIN, University Hospital, Clermont-Ferrand
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CHU-374
- 2017-A02975-49 (Other Identifier: 2017-A02975-49)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vascular Access
-
Shanghai Zhongshan HospitalUnknownVascular Access Complication | Vascular Access Site Occlusion | Vascular Access Malfunction
-
Sohag UniversityNot yet recruitingVascular Access | Ultrasound Guided Vascular Access
-
The University of QueenslandAustralasian Kidney Trials NetworkActive, not recruitingVascular Access Complication | Hemodialysis Access Failure (Disorder)Netherlands, Switzerland, Canada, France, United Kingdom, Australia, Malaysia
-
Hospital General Universitario de ValenciaCompletedVascular Access Complication | Vascular Access Device ComplicationsSpain
-
University of OklahomaCompleted
-
Christie Medical Holdings, Inc.Completed
-
IRCCS Burlo GarofoloCompleted
-
Ege UniversityCompleted
-
Christie Medical Holdings, Inc.Completed
-
Shanghai 10th People's HospitalNot yet recruitingVascular Access ComplicationsChina
Clinical Trials on Standard care
-
Evandro Chagas Institute of Clinical ResearchAlejandro Marcel Hasslocher Moreno, MD MSc PhD student; Andrea Costa, MD PhD; Andrea Silvestre de Sousa, MD PhD and other collaboratorsUnknownChagas Heart DiseaseBrazil
-
Neuroscience Trials AustraliaNational Institute for Health Research, United Kingdom; Northern Ireland Chest... and other collaboratorsCompleted
-
University of OklahomaNational Cancer Institute (NCI)CompletedSmoking CessationUnited States
-
Avita MedicalNAMSACompletedVenous Leg UlcersUnited Kingdom, France
-
University of MichiganCompleted
-
University of OklahomaCompletedTobacco Cessation | Tobacco Use | Tobacco Smoking | Smoking Cessation Financial Incentives | Socioeconomic Status | Contingency ManagementUnited States
-
University of OklahomaEnrolling by invitationTobacco Cessation | Tobacco Use | Tobacco Smoking | Smoking Cessation Financial Incentives | Socioeconomic Status | Contingency Management | PregnancyUnited States
-
Institut de Cancérologie de LorraineTerminatedBreast CancerFrance
-
Indonesia UniversityCompletedCovid19 | AcupunctureIndonesia
-
Johns Hopkins UniversityRecruitingCompartment Syndrome of Leg | Extracorporeal Membrane Oxygenation Complication | Limb Ischemia, Critical | Limb IschemiaUnited States